Glenmark Pharmaceuticals standalone net profit rises 49.35% in the September 2016 quarter
Sales rise 29.58% to Rs 2033.97 crore
Net profit of Glenmark Pharmaceuticals rose 49.35% to Rs 555.83 crore in the quarter ended September 2016 as against Rs 372.17 crore during the previous quarter ended September 2015. Sales rose 29.58% to Rs 2033.97 crore in the quarter ended September 2016 as against Rs 1569.69 crore during the previous quarter ended September 2015. ParticularsQuarter EndedSep. 2016Sep. 2015% Var.Sales2033.971569.69 30 OPM %38.4129.99 -PBDT733.13488.74 50 PBT707.33463.69 53 NP555.83372.17 49Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
More From This Section
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Oct 28 2016 | 7:57 AM IST